Platelet Function Analysis After In Vitro Treatment with Hemostasis-Affecting Components

Abstract

An overall platelet function test in whole blood, which simulates conditions under arterial pressure, is useful in measuring the effect of polymer materials on blood hemostatic function. We performed biocompatibility tests with materials or plasma substitutes by interaction of blood from healthy volunteers and then subjected these blood samples to platelet function analysis (Thrombostat). We tested also the capacity of locally applied hemostatic agents for bleeding control by direct application of these agents onto the Thrombostat measuring cell. The biocompatibility tests with materials exposed to blood appeared very discriminating between compatible and noncompatible materials. The hemostatic capacity of blood exposed to noncompatible materials (assessed by binding of active thrombin) reduced markedly after one hour incubation of the material. The plasma substitutes did not affect hemostasis significantly. However, a blood dilution of 40%, as in cardiopulmonary bypass, increased the time required for closure of the measuring cell by a platelet plug exponentially. Local hemostatic agents could be selected according to their capacity to enhance platelet plug formation. In addition, ADP mixed with the hemostatic agent was most effective in improving capacity. We conclude that platelet function analysis contributes importantly to screening of materials and plasma substitutes with regard to their interaction with primary hemostasis.

Keywords

Biomaterials - plasma substitutes - hemostatic agents - Thrombostat - primary hemostasis

• References

• 1 Dewanjee MK, Kapadvanjwala M, Cavagnaro CF, Panoutsopoulos GK, Suguihara CY, Elson R, Ezuddin SH, Serafini AN, Zillemelo GE, Sfakianakis GN. In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radiolabeled platelets. ASAIO J 40: 49-55 1994;
• 2 Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 70: 1673-1678 1987;
• 3 Brass LF, Ahuja M, Belmonte E, Pizarro S, Tarver A, Hoxie JA. The human platelet thrombin receptor. Ann NY Acad Sci 714: 1-12 1993;
• 4 Chuang HYK, Mohammed SF, Sharma NC, Mason RG. Interaction of human α-thrombin with artificial surfaces and reactivity of adsorbed α-thrombin. J Biomed Mat Res 14: 467-476 1980;
• 5 Pasche B, Kodama K, Larm O, Oisson P, Swedenborg J. Thrombin inactivation on surfaces with covalently bounded heparin. Thromb Res 44: 739-748 1986;
• 6 Strauss RG, Stump DC, Henriksen A, Saunders R. Effects on hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 25: 230-234 1985;
• 7 Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularisation. Ann Thorac Surg 37: 40-46 1984;
• 8 Kuitunen A, Hynynen M, Salmenperä M, Heinonen L, Vahtera E, Verkkala K, Myllylä G. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on hemostasis. Acta Anesthesiol Scand 37: 652-658 1993;
• 9 Dietrich G, Kretschmer V, Orth D, Haupt W. Primary hemostasis in hemodilution-2) Infusion solutions. Infusiontherapie 17: 214-216 1990;
• 10 Dietrich G, Kretschmer V, Orth D, Haupt W. Primary hemostasis in hemodilution 1) haematocrit. Infusionstherapie 17: 212-213 1990;
• 11 Kratzer MAA, Bellucci S, Caen JP. Detection of abnormal platelet functions with an in vitro model of primary haemostasis. Haemostasis 15: 363-370 1985;
• 12 Kristensen J, Eriksson L, Olsson K, Killander A, Högman C. Functional capacity of transfused platelets estimated by the Thrombostat 4000/2. Eur J Haematol 51: 152-155 1993;
• 13 Concrite EP, Lozner EL, Deaver JM. Experiments with use of thrombin with or without solubel cellulose for local hemostasis. War Med 5: 80-82 1944;
• 14 Sternberger A, Blümel G. Fibrinogen-fibrin conversion and inhibition of fibrinolysis. Thorac Cardiovasc Surg 30: 209-214 1982;
• 15 Rousou JA, Engelman RM, Breyer RH. Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg 38: 409-410 1984;